CVS:NYE-CVS Health Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 63.48

Change

-1.61 (-2.47)%

Market Cap

N/A

Volume

0.01B

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

-36.00 (-7.17%)

USD 481.78B
ELV Elevance Health Inc

-5.40 (-1.38%)

USD 90.78B
CNC Centene Corp

-0.80 (-1.37%)

USD 28.20B
MOH Molina Healthcare Inc

-7.65 (-2.62%)

USD 15.11B
OSCR Oscar Health Inc

-1.25 (-7.78%)

USD 4.10B
NEUE NeueHealth Inc

-0.04 (-0.54%)

USD 0.06B
CI Cigna Corp

+0.13 (+0.04%)

N/A
HUM Humana Inc

-15.39 (-5.67%)

N/A

ETFs Containing CVS

WBIY WBI Power Factor® High D.. 5.99 % 0.70 %

-0.16 (-1.44%)

USD 0.06B
XFVT:XETRA 4.04 % 0.00 %

N/A

N/A
MDPL Northern Lights Fund Trus.. 3.89 % 0.00 %

-0.09 (-1.44%)

USD 0.06B
UNCU:LSE First Trust US Equity Inc.. 2.79 % 0.00 %

+0.16 (+-1.44%)

USD 0.04B
SDOG ALPS Sector Dividend Dogs.. 2.67 % 0.40 %

-0.26 (-1.44%)

USD 1.23B
ESN Essential 40 Stock ETF 2.60 % 0.00 %

-0.23 (-1.44%)

USD 0.08B
XHS SPDR® S&P Health Care Se.. 2.34 % 0.35 %

-3.71 (-1.44%)

USD 0.08B
VMAX REX VolMAXX Long VIX Futu.. 1.90 % 0.00 %

-0.69 (-1.44%)

USD 0.05B
SPYD SPDR® Portfolio S&P 500 .. 1.45 % 0.08 %

-0.03 (-1.44%)

USD 6.82B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

+0.18 (+-1.44%)

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

+0.13 (+-1.44%)

USD 0.08B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

+0.02 (+-1.44%)

N/A
SYBN:F 0.37 % 0.00 %

N/A

N/A
SYBN:XETRA 0.37 % 0.00 %

N/A

N/A
SYBR:F 0.30 % 0.00 %

N/A

N/A
SYBR:XETRA 0.30 % 0.00 %

N/A

N/A
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

+0.04 (+-1.44%)

USD 0.40B
SPED:LSE Invesco S&P 500 Equal Wei.. 0.26 % 0.00 %

-0.07 (-1.44%)

USD 0.23B
SPEQ:LSE Invesco S&P 500 Equal Wei.. 0.26 % 0.00 %

-0.05 (-1.44%)

USD 0.66B
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

+0.17 (+-1.44%)

USD 0.90B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

+0.01 (+-1.44%)

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

-0.13 (-1.44%)

USD 0.04B
FEX First Trust Large Cap Cor.. 0.00 % 0.61 %

-1.90 (-1.44%)

USD 1.33B
FXG First Trust Consumer Stap.. 0.00 % 0.64 %

+0.39 (+-1.44%)

USD 0.30B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

-1.82 (-1.44%)

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

+0.33 (+-1.44%)

USD 0.61B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

+0.38 (+-1.44%)

N/A
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

+0.12 (+-1.44%)

USD 0.90B
EQRR ProShares Equities for Ri.. 0.00 % 0.35 %

-0.89 (-1.44%)

USD 0.01B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

+0.08 (+-1.44%)

USD 0.09B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

+0.24 (+-1.44%)

USD 2.67B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

+0.03 (+-1.44%)

USD 2.59B
SSPY Exchange Listed Funds Tru.. 0.00 % 0.00 %

-1.10 (-1.44%)

USD 0.09B
RTH VanEck Retail ETF 0.00 % 0.35 %

-3.27 (-1.44%)

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

-1.61 (-1.44%)

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

+0.06 (+-1.44%)

USD 2.19B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

-0.62 (-1.44%)

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

-0.62 (-1.44%)

N/A
ICAN 0.00 % 0.50 %

N/A

N/A
FEX:LSE First Trust US Large Cap .. 0.00 % 0.00 %

-7.50 (-1.44%)

USD 0.12B
FEXD:LSE First Trust US Large Cap .. 0.00 % 0.00 %

-5.00 (-1.44%)

USD 0.04B
FEXU:LSE First Trust Global Funds .. 0.00 % 0.00 %

-0.08 (-1.44%)

USD 0.12B
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

+3.50 (+-1.44%)

USD 0.09B
UINC:LSE First Trust US Equity Inc.. 0.00 % 0.00 %

+7.50 (+-1.44%)

USD 0.31B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
XVTD:LSE Xtrackers - FTSE Vietnam .. 0.00 % 0.00 %

+0.03 (+-1.44%)

USD 0.25B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
ZPRU:XETRA 0.00 % 0.00 %

N/A

N/A
XFVT:SW Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

+0.25 (+-1.44%)

USD 0.24B
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A
SHUS Exchange Listed Funds Tru.. 0.00 % 0.00 %

-0.59 (-1.44%)

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 41.41% 100% F 99% N/A
Dividend Return 1.48% 100% F 72% C
Total Return 42.89% 100% F 99% N/A
Trailing 12 Months  
Capital Gain -17.77% 56% F 13% F
Dividend Return 3.45% 100% F 52% F
Total Return -14.33% 56% F 13% F
Trailing 5 Years  
Capital Gain -11.23% 50% F 37% F
Dividend Return 16.00% 100% F 54% F
Total Return 4.78% 50% F 33% F
Average Annual (5 Year Horizon)  
Capital Gain 0.26% 33% F 33% F
Dividend Return 2.79% 56% F 35% F
Total Return 2.53% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 29.71% 22% F 36% F
Risk Adjusted Return 9.41% 56% F 26% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector